Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why the FTC has declared war on doctors.

R L Peck

    Medical Economics
    |July 16, 1979
    PubMed
    Summary
    This summary is machine-generated.

    The Federal Trade Commission (FTC) actively intervenes against anti-competitive practices in healthcare, including advertising restrictions and provider limitations. This ensures competition is protected within the medical field.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Discovery, development, and antimicrobial properties of D-4-amino-3-isoxazolidone (oxamycin), a new antibiotic produced by Streptomyces garyphalus n. sp.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Streptomyces antibiotics; dihydrostreptomycin.

    Journal of the American Chemical Society·2010
    Same author

    Streptomyces antibiotics; isolation of streptomycin.

    Journal of the American Chemical Society·2010
    Same author

    Streptomyces antibiotics; hydrolytic cleavage of streptomycin to streptidine.

    Journal of the American Chemical Society·2010
    Same author

    Streptomyces antibiotics; isolation of streptothricin.

    Journal of the American Chemical Society·2010
    Same author

    Streptomyces antibiotics; the structure of streptidine.

    Journal of the American Chemical Society·2010
    Same journal

    Direct primary care may become the norm.

    Medical economics·2016
    Same journal

    Independent doctors find success with physician-led ACOs.

    Medical economics·2016
    Same journal

    Bundled pay brings physicians greater risks and rewards.

    Medical economics·2016
    Same journal

    Discharging problem patients the right way.

    Medical economics·2016
    Same journal

    How cyberattacks can impact physicians.

    Medical economics·2016
    Same journal

    What active patient management means when billing incident-to.

    Medical economics·2016
    See all related articles

    Area of Science:

    • Health Policy
    • Antitrust Law
    • Medical Economics

    Background:

    • The Federal Trade Commission (FTC) has taken significant actions against various medical entities.
    • Interviews with FTC staff reveal the agency's perspective on healthcare competition.

    Purpose of the Study:

    • To review the FTC's enforcement actions against medical societies and healthcare organizations.
    • To understand the FTC's stance on competition within the medical practice landscape.

    Main Methods:

    • Review of FTC actions against medical societies, Blue Shield directors, Health Systems Agencies, and Professional Services Review Organizations.
    • Interviews with high-ranking FTC staff officers to gather insights into agency concerns.

    Main Results:

    Related Experiment Videos

    • The FTC views the practice of medicine as an area where competition must be safeguarded.
    • Practices such as advertising restrictions, fixed fee schedules, physician number limitations, and exclusion of other providers are deemed anti-competitive.
    • The FTC's intervention is warranted for such anti-competitive actions.

    Conclusions:

    • The FTC is committed to protecting competition in healthcare services.
    • Legislation by Congress to control healthcare costs may permit practices that the FTC would otherwise oppose.